The Relationship between Rate and Volume of Intravenous Fluid Administration and Kidney Outcomes after Angiography

医学 四分位间距 四分位数 优势比 置信区间 肌酐 内科学
作者
Qandeel H. Soomro,Sonia T. Anand,Steven D. Weisbord,Martin Gallagher,Ryan Ferguson,Paul M. Palevsky,Deepak L. Bhatt,Chirag R. Parikh,James S. Kaufman
出处
期刊:Clinical Journal of The American Society of Nephrology [Lippincott Williams & Wilkins]
卷期号:17 (10): 1446-1456 被引量:6
标识
DOI:10.2215/cjn.02160222
摘要

Contrast-associated AKI may result in higher morbidity and mortality. Intravenous fluid administration remains the mainstay for prevention. There is a lack of consensus on the optimal administration strategy. We studied the association of periprocedure fluid administration with contrast-associated AKI, defined as an increase in serum creatinine of at least 25% or 0.5 mg/dl from baseline at 3-5 days after angiography, and 90-day need for dialysis, death, or a 50% increase in serum creatinine.We conducted a secondary analysis of 4671 PRESERVE participants who underwent angiographic procedures. Although fluid type was randomized, strategy of administration was at the discretion of the clinician. We divided the study cohort into quartiles by total fluid volume. We performed multivariable logistic regression, adjusting for clinically important covariates. We tested for the interaction between fluid volume and duration of fluid administration, categorized as <6 or ≥6 hours.The mean (SD) age was 70 (8) years, 94% of participants were male, and median (interquartile range) eGFR was 60 (41-60) ml/min per 1.73 m2. The range of fluid administered was 89-882 ml in quartile 1 and 1258-2790 ml in quartile 4. Compared with the highest quartile (quartile 4) of fluid volume, we found a significantly higher risk of the primary outcome in quartile 1 (adjusted odds ratio, 1.58; 95% confidence interval, 1.06 to 2.38) but not in quartiles 2 and 3 compared with quartile 4. There was no difference in the incidence of contrast-associated AKI across the quartiles. The interaction between volume and duration was not significant for any of the outcomes.We found that administration of a total volume of 1000 ml, starting at least 1 hour before contrast injection and continuing postcontrast for a total of 6 hours, is associated with a similar risk of adverse outcomes as larger volumes of intravenous fluids administered for periods >6 hours. Mean fluid volumes <964 ml may be associated with a higher risk for the primary outcome, although residual confounding cannot be excluded.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
Ran发布了新的文献求助10
1秒前
隐形曼青应助Della采纳,获得10
2秒前
yitai完成签到,获得积分10
2秒前
jjjjj发布了新的文献求助30
3秒前
杜兰特发布了新的文献求助20
4秒前
6秒前
木心应助负责小蜜蜂采纳,获得10
6秒前
Rondab应助负责小蜜蜂采纳,获得30
6秒前
shenzhou9发布了新的文献求助10
7秒前
7秒前
8秒前
8秒前
10秒前
rrgogo发布了新的文献求助10
10秒前
10秒前
酷波er应助展希希采纳,获得10
11秒前
慕青应助xn201120采纳,获得10
12秒前
七七完成签到,获得积分10
12秒前
Della发布了新的文献求助10
13秒前
gogoyoco发布了新的文献求助10
13秒前
符小俊完成签到,获得积分10
15秒前
旷野发布了新的文献求助10
15秒前
mammer完成签到,获得积分10
16秒前
左肩微笑完成签到,获得积分10
16秒前
来来完成签到,获得积分10
18秒前
Cochrane完成签到,获得积分0
18秒前
Hey关闭了Hey文献求助
19秒前
jjjjj完成签到,获得积分20
20秒前
20秒前
8R60d8应助yitai采纳,获得10
21秒前
科研助手6应助yitai采纳,获得10
21秒前
脑洞疼应助man采纳,获得10
21秒前
来来发布了新的文献求助10
21秒前
yizhiGao应助科研通管家采纳,获得10
23秒前
思源应助科研通管家采纳,获得10
23秒前
Akim应助科研通管家采纳,获得10
23秒前
852应助科研通管家采纳,获得10
23秒前
JamesPei应助科研通管家采纳,获得10
23秒前
柯一一应助科研通管家采纳,获得10
23秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989550
求助须知:如何正确求助?哪些是违规求助? 3531774
关于积分的说明 11254747
捐赠科研通 3270278
什么是DOI,文献DOI怎么找? 1804966
邀请新用户注册赠送积分活动 882125
科研通“疑难数据库(出版商)”最低求助积分说明 809176